 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/14/2021 |
$80.65 |
$83.22 |
$80.54 |
$82.21 |
1.04M | | 04/15/2021 |
$82.87 |
$84.17 |
$82.44 |
$83.20 |
714.00K | | 04/16/2021 |
$83.62 |
$83.87 |
$81.52 |
$82.68 |
999.00K | | 04/19/2021 |
$82.79 |
$83.72 |
$81.67 |
$82.67 |
1.04M | | 04/20/2021 |
$82.90 |
$84.64 |
$82.90 |
$84.57 |
735.60K |
|
|
| Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. JAKAFI (ruxolitinib) has been approved for the treatment of adults with intermediate or high-risk myelofibrosis, for the treatment of adults with polycythemia vera, and for the treatment of steroid-refractory acute graft-versus-host disease in adult and pediatric patients 12 years and older. Co. has also obtained a license to develop and commercialize ICLUSIG (ponatinib) in Europe and other select countries. In the European Union, ICLUSIG is approved for the treatment of adult patients with chronic phase, accelerated phase or blast phase chronic myeloid leukemia. | |
|
Incyte (INCY) has the following price history information. Looking back at INCY historical stock prices for the last five trading days, on April 14, 2021, INCY opened at $80.65, traded as high as $83.22 and as low as $80.54, and closed at $82.21. Trading volume was a total of 1.04M shares. On April 15, 2021, INCY opened at $82.87, traded as high as $84.17 and as low as $82.44, and closed at $83.20. Trading volume was a total of 714.00K shares. On April 16, 2021, INCY opened at $83.62, traded as high as $83.87 and as low as $81.52, and closed at $82.68. Trading volume was a total of 999.00K shares. On April 19, 2021, INCY opened at $82.79, traded as high as $83.72 and as low as $81.67, and closed at $82.67. Trading volume was a total of 1.04M shares. On April 20, 2021, INCY opened at $82.90, traded as high as $84.64 and as low as $82.90, and closed at $84.57. Trading volume was a total of 735.60K shares.
INCY Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Incyte shares, starting with a $10,000 purchase of INCY, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/21/2011 |
|
| End date: |
04/20/2021 |
|
| Start price/share: |
$17.72 |
|
| End price/share: |
$84.57 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
377.26% |
|
| Average Annual Total Return: |
16.91% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$47,740.66 |
|
| Years: |
10.01 |
|
|
|
| Date |
Close |
| 04/14/2021 | $82.21 | | 04/15/2021 | $83.20 | | 04/16/2021 | $82.68 | | 04/19/2021 | $82.67 | | 04/20/2021 | $84.57 |
|
|
